GLUE
Monte Rosa Therapeutics Inc
11.90$
-5.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.0% | 88.3% | 95.2% | 80.6% | 77.8% | 86.0% | 87.6% | |
| 54.0% | 84.4% | 94.5% | 16.0% | 42.2% | 51.1% | 28.9% | |
| 54.0% | 84.4% | 94.5% | 76.8% | 76.5% | 84.8% | 84.1% | |
| 0.5% | 0.2% | – | 2.2% | 0.2% | 0.0% | 1.0% | |
| – | – | – | 0.3% | – | – | – | |
| 12.0% | 9.4% | 3.4% | 7.9% | – | – | – | |
| 209.5% | 198.7% | 5.1% | 20.7% | 41.0% | 49.2% | 48.1% | |
| 38.7% | 59.3% | 4.5% | 7.5% | 15.3% | 35.8% | 14.3% | |
| 6.8% | – | – | 0.9% | 1.0% | 0.8% | 1.0% | |
| 28.8% | 14.3% | 1.8% | 2.3% | 3.7% | 3.9% | 0.8% | |
| -109.5% | -98.7% | 94.9% | 79.3% | 59.0% | 50.8% | 51.9% | |
| -110.0% | -97.4% | -33.3% | -67.3% | -120.5% | -100.0% | -106.4% | |
| 396.6% | 89.1% | 12.7% | 13.8% | 16.9% | 16.8% | 14.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.